A case report published in Cureus on October 15, 2026 describes persistent inflammation on one side of a patient's face that was associated with a foreign-body reaction to calcium hydroxylapatite. According to Cureus, the reaction was described as compatible with the filler material.
The report focuses on a single patient, and the available summary does not include details such as the patient's age, the timing of the procedure, or how the condition was managed. No information was provided on the outcome.
Calcium hydroxylapatite is a material used in injectable dermal fillers. In a foreign-body reaction, the body's immune system responds to a substance it treats as foreign, which can produce swelling and inflammation. The Cureus report frames the patient's ongoing one-sided facial inflammation in that context.
Because this is a case report, it documents one patient's experience rather than establishing how often such reactions occur or whether calcium hydroxylapatite is more likely to cause them than other fillers. The summary does not compare this case with other products or with other patients.
What to watch next: whether additional case reports or larger studies examine the frequency and management of foreign-body reactions to calcium hydroxylapatite fillers.